Deep Venous Thrombosis
Cardiovascular
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
GSKEnoxaparin
Clinical Trials (1)
Total enrollment: 198 patients across 1 trials
Comparing Enoxaparin to Fondaparinux to Prevent Venous Thromboembolism (VTE) in Bariatric Surgical Patients
Start: Jun 2009Est. completion: Sep 2013198 patients
Phase 1Completed
Related Jobs in Cardiovascular
Embedded Software and System Test Engineer (H/F)
Cardiawave
Levallois-Perret, France (Hybrid)
Just now
Visitador (a) Médico
Abbott
Dominican Republic - Santo Domingo
2d ago
Visitador Médico
Abbott
Nicaragua - Managua
2d ago
Clinical Specialist, Chronic MCS - Louisville, KY/Cincinnati, OH
Abbott
United States - Kentucky - Louisville
2d ago
$61K - $123K/yr
Territory Manager, CardioMEMS - San Antonio, TX
Abbott
United States - Texas - San Antonio
2d ago
$44K - $109K/yr
Director, Strategic & Growth Marketing - Abbott Heart Failure
Abbott
United States - California - Pleasanton
2d ago
$197K - $395K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space